RECORDATI AND HELSINN AGREEMENT FOR THE EXCLUSIVE COMMERCIALIZATION RIGHTS TO LEDAGA® 20 December 2018
Helsinn Group Announces new Permanent J Code for AKYNZEO® (fosnetupitant and palonosetron) for injection in the US 12 December 2018
Farma Industria Ticino and Ticino’s pharmaceutical companies in Madrid for CPhI Worldwide 2018 31 October 2018
Mundipharma brings its cancer supportive care expertise to Vietnam after signing agreement with Helsinn Group for ALOXI® (palonosetron HCl) 16 August 2018
Helsinn Therapeutics (U.S.) Inc. becomes the exclusive distributor of ALOXI® (palonosetron HCI) in the U.S. 2 July 2018
Helsinn Group and Angelini support Satellite Symposium at MASCC/ISOO 2018 Annual Meeting 26 June 2018
Linkedin